![](/img/cover-not-exists.png)
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer
Fogelman, David, Cubillo, Antonio, García-Alfonso, Pilar, Mirón, María Luisa Limón, Nemunaitis, John, Flora, Daniel, Borg, Christophe, Mineur, Laurent, Vieitez, Jose M., Cohn, Allen, Saylors, Gene, AsLanguage:
english
Journal:
Cancer Medicine
DOI:
10.1002/cam4.1703
Date:
August, 2018
File:
PDF, 333 KB
english, 2018